|
|
||||||||
Département de Pharmacologie, Université René Descartes and Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8604, Faculté de Médecine, 75015 Paris, France
Ca2+ channel blockers, such as amlodipine, inhibit vascular smooth muscle cell (VSMC) growth through interactions with targets other than L-type Ca2+ channels. The effects of amlodipine on Ca2+ movements in thrombin- and thapsigargin-stimulated VSMCs were therefore investigated by determining the variations of intracellular free Ca2+ concentration in fura 2-loaded cultured VSMCs. Results indicated that 10-1,000 nM amlodipine inhibited 1) thrombin-induced Ca2+ mobilization from a thapsigargin-sensitive pool and 2) thapsigargin-induced Ca2+ responses, including Ca2+ mobilization from internal stores and store-operated Ca2+ entry. These effects of amlodipine do not involve L-type Ca2+ channels and could not be reproduced with 100 nM isradipine, diltiazem, or verapamil. The inhibition by amlodipine of Ca2+ mobilization appears therefore to be a specific property of the drug, in addition to its Ca2+ channel-blocking property. It is suggested that amlodipine acts in this capacity by interacting with Ca2+-ATPases of the sarcoplasmic reticulum, thus modulating the enzyme activity. This mechanism might participate in the inhibitory effect of amlodipine on VSMC growth.
calcium channel blockers; calcium mobilization; vascular smooth muscle cell growth
This article has been cited by other articles:
![]() |
Y. K. B. Siddegowda, M. D. M. Leo, D. Kumar, O. K. Hooda, V. R. Prakash, and S. K. Mishra Vascular: Influence of heat stress on the reactivity of isolated chicken carotid artery to vasoactive agents Exp Physiol, November 1, 2007; 92(6): 1077 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Beech, K. Muraki, and R. Flemming Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP J. Physiol., September 15, 2004; 559(3): 685 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, W. Kwon, E. Weinman, and T. L. Pallone ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H773 - H781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.P. Mason, P. Marche, and T.H. Hintze Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists: Ancillary Actions of Amlodipine Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2155 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bobe, X. Yin, M.-C. Roussanne, O. Stepien, E. Polidano, C. Faverdin, and P. Marche Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H745 - H754. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, W. G. Wier, and M. P. Blaustein Mg2+ blocks myogenic tone but not K+-induced constriction: role for SOCs in small arteries Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2692 - H2705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |